Turkey is a prominent destination for esophageal cancer treatment, with top-tier centers like Anadolu Medical Center, Hisar Hospital Intercontinental, and Memorial Şişli Hospital accredited by the Joint Commission International. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, is recognized for advanced oncology services, while Hisar Hospital attracts over 500,000 patients annually. Memorial Şişli Hospital, the first in Turkey with JCI accreditation, is known for innovative procedures.
Turkey's centers employ procedures like minimally invasive esophagectomy, robotic-assisted surgery, endoscopic submucosal dissection (ESD), and targeted therapy. According to recent research, perioperative chemotherapy protocols like FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) significantly improve survival rates to 57.4% at 3 years for patients with esophageal adenocarcinoma. Turkish oncology centers have adopted these evidence-based protocols, enhancing their reputation in specialized cancer care.